Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Valeo Pharma Inc VPHIF

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.


GREY:VPHIF - Post by User

Comment by FootonJohnon Oct 13, 2020 3:14pm
122 Views
Post# 31708356

RE:RE:My HesperCo order is in transit

RE:RE:My HesperCo order is in transitThanks. Awesome, I'm Amazon Prime so hopefully this item qualifies. Super fast delivery if so. I did some research on Hesperidin; it has been used for decades without negative issues. Also will be convenient for me when Walmart pharmacy gets it. 

Good piece of mind: The doses and purity and process and sources do make a difference; there is no competition to what Valeo offers.

recommended reading:

Synopsis of scientific research on what hesperidin has been discovered to do (primarily based on research done primarily on SARS over a decade ago, which is also a coronavirus).

https://marketequitiesresearch.com/marketbulletin-vph-hesperco-sept4-2020.htm

and

for those not up to speed on Company see technology article https://technologymarketwatch.com/vph.htm



<< Previous
Bullboard Posts
Next >>